Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

AVITA Raises 2026 Revenue Guidance Again After Quarterly Sales Jump

AVH: $4.55 -1.73% · MC: $778M

AVITA Medical lifted its 2026 revenue forecast for a second time, to approximately $92 million–$94 million, from $86 million–$89 million, after third-quarter revenue rose 53% year on year and 20% from the previous quarter. It reaffirmed its expectation of cash-flow breakeven in the fourth quarter; separately, Medicare finalized national physician payment valuations and a simpler billing-code structure for RECELL procedures from 2027.

Source announcements: 2026-11-06 08:21 to 2026-11-06 11:56 Sydney time
Story updated 2026-11-06 12:01 Sydney time
SourcesAVITA Medical Announces Q3 2026 Financial ResultsAVITA Q3 Financial Results Earning PresentationAVITA 10Q Quarterly Reports for Q3 2026AVITA announce CMS Finalized Valuations and Codes for RECELLStatement of CDIs on issue - AVH
Comments